Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 11Prostatic Neoplasms 5Ovarian Neoplasms 5Neoplasms 5Stomach Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Leukemia, Myeloid, Acute 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Thromboembolism 1Thrombocytopenia 1Stomatitis 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Scleroderma, Localized 1Psoriasis 1Postoperative Hemorrhage 1Pleural Effusion 1Peritoneal Neoplasms 1Pancreatic Cyst 1Pain, Postoperative 1Pain 1

Interventions

vandetanib 2Tyrosine Kinase Inhibitors 1Tenecteplase 1Saline Solution 1Receptors, Vascular Endothelial Growth Factor 1Pemetrexed 1Octreotide 1Gemcitabine 1Dasatinib 1Darbepoetin alfa 1Cisplatin 1Cdc25C phosphatase (211-221) 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pleural Effusion × Saline Solution × Clear all
NCT01580618 2026-04-14

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Kaiser Permanente

Phase 2/3 Terminated
20 enrolled 11 charts
Thoracic

Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡